Invention Grant
- Patent Title: Method of treatment
- Patent Title (中): 治疗方法
-
Application No.: US14355964Application Date: 2012-11-02
-
Publication No.: US09242962B2Publication Date: 2016-01-26
- Inventor: Anna K. Bassil , Soren Beinke , Rabinder Kumar Prinjha
- Applicant: GlaxoSmithKline Intellectual Property (No. 2) Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
- Current Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Duke M. Fitch; Edward R. Gimmi; William R. Majarian
- International Application: PCT/US2012/063235 WO 20121102
- International Announcement: WO2013/067296 WO 20130510
- Main IPC: A61K31/497
- IPC: A61K31/497 ; C07D401/14 ; C12N9/10 ; A61K31/4439 ; A61K31/405
Abstract:
The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20140256739A1 METHOD OF TREATMENT Public/Granted day:2014-09-11
Information query
IPC分类:
